JPRN-UMIN000006634
Completed
未知
Pharmacokinetics and pharmacogenomics study with erlotinib in the treatment of advanced non-small cell lung cancer (NSCLC) - PK/PG study with erlotinib in NSCLC
Department of Respiratory Medicine / Keio Cancer Center, School of Medicine, Keio University0 sites40 target enrollmentNovember 1, 2011
Conditionson-small cell lung cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- on-small cell lung cancer
- Sponsor
- Department of Respiratory Medicine / Keio Cancer Center, School of Medicine, Keio University
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Without concent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical pharmacology and pharmacogenetic study on the clinical response for tamoxifeBreast cancerJPRN-UMIN000001411Saitama Medical University, Saitama International Medical Center100
Completed
Not Applicable
Research of pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of 5-Fluorouracil in colorectal cancer patientsColorectal cancerJPRN-UMIN000004095Department of clinical pharmacokinetics, Graduate school of Pharmaceutical Science, Kyushu University30
Recruiting
Not Applicable
An exploratory pharmacokinetic and pharmacodynamic study of beta-lactam and fluoroquinolone in ICU patientsSepsisbacterial infection10004018NL-OMON43959Erasmus MC, Universitair Medisch Centrum Rotterdam200
Not yet recruiting
Not Applicable
Examining the pharmacokinetic and pharmacodynamic profile of biperidegeheugen/ memoryNL-OMON24672Maastricht University27
Recruiting
Not Applicable
Examining the pharmacokinetic and pharmacodynamic profile of biperideNL-OMON47428niversiteit Maastricht42